Latest news with #consumersector
Yahoo
15 hours ago
- Business
- Yahoo
J.P. Morgan, Houlihan Lokey lead consumer sector financial adviser M&A rankings in H1
J.P. Morgan and Houlihan Lokey led the mergers and acquisitions (M&A) financial advisory rankings in the consumer sector for the first half (H1) of 2025, in terms of value and volume, respectively, according to the latest financial advisers league table by leading data and analytics company GlobalData. J.P. Morgan topped by deal value, with $7.2bn in advised deals. In the value-based rankings, Citi secured the second place with $4.5bn in advised deals. It was followed by Centerview Partners at $2.7bn, Goldman Sachs at $2.5bn, and Barclays at $2.3bn. Meanwhile, Houlihan Lokey led by deal volume with advisory on ten transactions. Rothschild & Co, PwC, and Spayne Lindsay & Co. each advised on nine deals. Deloitte and KPMG tied for fifth, each handling eight deals. GlobalData lead analyst Aurojyoti Bose said: 'Both J.P. Morgan and Houlihan Lokey were the top advisers by value and volume, respectively, in H1 2024, and managed to retain their respective leadership positions by these metrics in H1 2025 as well. 'Despite registering a year-on-year decline in the total number of deals advised by it, Houlihan Lokey was the only adviser to hit double-digit deal volume during H1 2025. 'Meanwhile, J.P. Morgan experienced around 10% growth in the total value of deals advised by it during H1 2025 compared to H1 2024. Apart from leading by value, JP Morgan also held the seventh position by volume during H1 2025.' GlobalData's league tables are based on the real-time tracking of thousands of company websites, advisory business websites and other reliable sources available on the secondary domain. A dedicated team of analysts monitors all these sources to gather in-depth details for each deal, including adviser names. To ensure further robustness of the data, the company also seeks submissions of deals from leading advisers. "J.P. Morgan, Houlihan Lokey lead consumer sector financial adviser M&A rankings in H1" was originally created and published by Packaging Gateway, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Bloomberg
14-07-2025
- Business
- Bloomberg
Kenvue, Kraft Heinz Step Up Brand Management
Hi, it's Crystal Tse in New York, taking a closer look at some big strategic reviews in the US consumer sector. Elsewhere, Donald Trump's FTC chair is becoming the MAGA answer to Lina Khan. Today's top stories
Yahoo
14-07-2025
- Business
- Yahoo
Temasek eyes more Indian family-run businesses after Haldiram's deal
By Dhwani Pandya MUMBAI (Reuters) -Singapore's state investor Temasek is looking to invest more in Indian family-run businesses, a top executive said on Monday, months after it invested $1 billion in a popular domestic snacks company. Family businesses in India, with their multigenerational legacies, strong domestic brands and loyal customers, have become attractive for global investors in recent years. In March, Temasek bought a 10% stake in Haldiram's at a valuation of around $10 billion, with sources describing it as a "prized asset" that will help investors expand its focus on India's consumer sector. "We've been very active in investing behind family-run businesses, we can invest across the value chain," Vishesh Shrivastav, managing director of Temasek's India investment team, said in an interview at its Mumbai office. Temasek has earlier invested in many businesses in India which were once run by business families, such as Manipal Hospitals and Dr Agarwal's Health Care. In a separate factsheet, Temasek said it was "keen to partner more family-owned businesses to drive long-term value creation." It did not name any potential targets. Temasek spent $2 billion in April 2023 to raise its stake in Manipal to 59% from 18% in the biggest hospital sector deal ever in India. It later sold a minority stake to Novo Nordisk's parent Novo Holdings and Abu Dhabi's sovereign investor Mubadala, but retained majority control of the hospital chain. Asked about Manipal Hospitals possible public offering, Shrivastav said it was "an eminently listable company," without elaborating. India continues to be Temasek's best-performing market over the last decade, as it remained the world's fastest-growing major economy and the second largest IPO market in 2025. Temasek said it maintained its positive outlook for India and its 2023 goal of investing up to $10 billion in Asia's third-largest economy over a three-year horizon. Temasek invested over $3 billion in India over the past year. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Reuters
14-07-2025
- Business
- Reuters
Temasek eyes more Indian family-run businesses after Haldiram's deal
MUMBAI, July 14 (Reuters) - Singapore's state investor Temasek is looking to invest more in Indian family-run businesses, a top executive said on Monday, months after it invested $1 billion in a popular domestic snacks company. Family businesses in India, with their multigenerational legacies, strong domestic brands and loyal customers, have become attractive for global investors in recent years. In March, Temasek bought a 10% stake in Haldiram's at a valuation of around $10 billion, with sources describing it as a "prized asset" that will help investors expand its focus on India's consumer sector. "We've been very active in investing behind family-run businesses, we can invest across the value chain," Vishesh Shrivastav, managing director of Temasek's India investment team, said in an interview at its Mumbai office. Temasek has earlier invested in many businesses in India which were once run by business families, such as Manipal Hospitals and Dr Agarwal's Health Care. In a separate factsheet, Temasek said it was "keen to partner more family-owned businesses to drive long-term value creation." It did not name any potential targets. Temasek spent $2 billion in April 2023 to raise its stake in Manipal to 59% from 18% in the biggest hospital sector deal ever in India. It later sold a minority stake to Novo Nordisk's parent Novo Holdings and Abu Dhabi's sovereign investor Mubadala, but retained majority control of the hospital chain. Asked about Manipal Hospitals possible public offering, Shrivastav said it was "an eminently listable company," without elaborating. India continues to be Temasek's best-performing market over the last decade, as it remained the world's fastest-growing major economy and the second largest IPO market in 2025. Temasek said it maintained its positive outlook for India and its 2023 goal of investing up to $10 billion in Asia's third-largest economy over a three-year horizon. Temasek invested over $3 billion in India over the past year.
Yahoo
14-07-2025
- Business
- Yahoo
Temasek eyes more Indian family-run businesses after Haldiram's deal
By Dhwani Pandya MUMBAI (Reuters) -Singapore's state investor Temasek is looking to invest more in Indian family-run businesses, a top executive said on Monday, months after it invested $1 billion in a popular domestic snacks company. Family businesses in India, with their multigenerational legacies, strong domestic brands and loyal customers, have become attractive for global investors in recent years. In March, Temasek bought a 10% stake in Haldiram's at a valuation of around $10 billion, with sources describing it as a "prized asset" that will help investors expand its focus on India's consumer sector. "We've been very active in investing behind family-run businesses, we can invest across the value chain," Vishesh Shrivastav, managing director of Temasek's India investment team, said in an interview at its Mumbai office. Temasek has earlier invested in many businesses in India which were once run by business families, such as Manipal Hospitals and Dr Agarwal's Health Care. In a separate factsheet, Temasek said it was "keen to partner more family-owned businesses to drive long-term value creation." It did not name any potential targets. Temasek spent $2 billion in April 2023 to raise its stake in Manipal to 59% from 18% in the biggest hospital sector deal ever in India. It later sold a minority stake to Novo Nordisk's parent Novo Holdings and Abu Dhabi's sovereign investor Mubadala, but retained majority control of the hospital chain. Asked about Manipal Hospitals possible public offering, Shrivastav said it was "an eminently listable company," without elaborating. India continues to be Temasek's best-performing market over the last decade, as it remained the world's fastest-growing major economy and the second largest IPO market in 2025. Temasek said it maintained its positive outlook for India and its 2023 goal of investing up to $10 billion in Asia's third-largest economy over a three-year horizon. Temasek invested over $3 billion in India over the past year. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
